Pathological importance of the endothelin-1/ET B receptor system on vascular diseases

Cardiology Research and Practice

Volumn 1, Issue 1, 2012, Pages

  Kitada, Kento ^a,b   Ohkita, Mamoru ^a   Matsumura, Yasuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIG ENDOTHELIN 1; COLLAGEN; DEOXYCORTICOSTERONE ACETATE; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; ENDOTHELIN RECEPTOR ANTAGONIST; EPIDERMAL GROWTH FACTOR; ESTRADIOL; ESTROGEN; NITRIC OXIDE; PLATELET DERIVED GROWTH FACTOR;

ATHEROSCLEROSIS; CELL PROLIFERATION; DISEASE MODEL; DRUG ACTIVATION; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG CHOICE; DRUG MECHANISM; ENDOTHELIUM CELL; HUMAN; HYPERTENSION; NEOINTIMA; NONHUMAN; PATHOPHYSIOLOGY; PHARMACOLOGICAL STIMULATION; PRIORITY JOURNAL; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; RESTENOSIS; REVIEW; SEX DIFFERENCE; VASCULAR DISEASE; VASCULAR HYPERTROPHY;

EID: 84864925717     PISSN: None     EISSN: 20900597     Source Type: Journal    
DOI: 10.1155/2012/731970     Document Type: Review

References (54)

1. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Goto K., Masaki T., Yazaki Y., A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 1988 332 6163 411 415 (Pubitemid 18090241)
2. Goto K., Hama H., Kasuya Y., Molecular pharmacology and pathophysiological significance of endothelin Japanese Journal of Pharmacology 1996 72 4 261 290 (Pubitemid 27039161)
3. Miyauchi T., Masaki T., Pathophysiology of endothelin in the cardiovascular system Annual Review of Physiology 1999 61 391 415 (Pubitemid 29143176)
4. Thorin E., Clozel M., The cardiovascular physiology and pharmacology of endothelin-1 Advances in Pharmacology 2010 60 1 26
5. Hirata Y., Takagi Y., Fukuda Y., Marumo F., Endothelin is a potent mitogen for rat vascular smooth muscle cells Atherosclerosis 1989 78 2-3 225 228 (Pubitemid 19195493)
6. Clozel M., Gray G. A., Breu V., Loffler B. M., Osterwalder R., The endothelin ET(B) receptor mediates both vasodilation and vasoconstriction in vivo Biochemical and Biophysical Research Communications 1992 186 2 867 873
7. Fukuroda T., Fujikawa T., Ozaki S., Ishikawa K., Yano M., Nishikibe M., Clearance of circulating endothelin-1 by ETB receptors in rats Biochemical and Biophysical Research Communications 1994 199 3 1461 1465
8. Kitada K., Yui N., Koyama M., Kimura K., Suzuki R., Tanaka R., Mori T., Ohkita M., Matsumura Y., Endothelin ETB receptor is involved in sex differences in the development of balloon injury-induced neointimal formation Journal of Pharmacology and Experimental Therapeutics 2011 336 2 533 539
9. Kitada K., Yui N., Matsumoto C., Mori T., Ohkita M., Matsumura Y., Inhibition of endothelin ETB receptor system aggravates neointimal hyperplasia after balloon injury of rat carotid artery Journal of Pharmacology and Experimental Therapeutics 2009 331 3 998 1004
10. Kirchengast M., Mnter K., Endothelin and restenosis Cardiovascular Research 1998 39 3 550 555 (Pubitemid 28407586)
11. Takahashi M., The role of endothelin-1 in vascular remodeling in vivo Cardiovascular Research 2006 71 1 4 5 (Pubitemid 43849679)
12. Wang X., Douglas S. A., Louden C., Vickery-Clark L. M., Feuerstein G. Z., Ohlstein E. H., Expression of endothelin-1, endothelin-3, endothelin-converting enzyme-1, and endothelin-A and endothelin-B receptor mRNA after angioplasty-induced neointimal formation in the rat Circulation Research 1996 78 2 322 328 (Pubitemid 26040860)
13. Douglas S. A., Louden C., Vickery-Clark L. M., Storer B. L., Hart T., Feuerstein G. Z., Elliott J. D., Ohlstein E. H., A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670 Circulation Research 1994 75 1 190 197
14. McKenna C. J., Burke S. E., Opgenorth T. J., Padley R. J., Camrud L. J., Camrud A. R., Johnson J., Carlson P. J., Lerman A., Holmes D. R., Schwartz R. S., Selective ET(A) receptor antagonism reduces neointimal hyperplasia in a porcine coronary stent model Circulation 1998 97 25 2551 2556 (Pubitemid 28294502)
15. Sanmartn M., Fernndez-Ortiz A., Fantidis P., Aragoncillo P., Fernndez-Durango R., Rolln R., Alfonso F., Hernndez R., Escaned J., Macaya C., Effects of bosentan on neointimal response following coronary angioplasty European Journal of Clinical Investigation 2003 33 9 762 768 (Pubitemid 37082862)
16. Takase H., Sugiyama M., Nakazawa A., Toriyama T., Hayashi K., Goto T., Sato K., Ikeda K., Ueda R., Dohi Y., Increased endogenous endothelin-1 in coronary circulation is associated with restenosis after coronary angioplasty Canadian Journal of Cardiology 2003 19 8 902 906 (Pubitemid 37069313)
17. Shirai N., Naruko T., Ohsawa M., Ikura Y., Sugama Y., Hirayama M., Kitabayashi C., Ehara S., Inoue T., Itoh A., Haze K., Tanzawa K., Yoshiyama M., Yoshikawa J., Ueda M., Expression of endothelin-converting enzyme, endothelin-1 and endothelin receptors at the site of percutaneous coronary intervention in humans Journal of Hypertension 2006 24 4 711 721
18. Iwasa S., Fan J., Shimokama T., Nagata M., Watanabe T., Increased immunoreactivity of endothelin-1 and endothelin B receptor in human atherosclerotic lesions. A possible role in atherogenesis Atherosclerosis 1999 146 1 93 100 (Pubitemid 29371866)
19. Kobayashi T., Miyauchi T., Iwasa S., Sakai S., Fan J., Nagata M., Goto K., Watanabe T., Corresponding distributions of increased endothelin-B receptor expression and increased endothelin-1 expression in the aorta of apolipoprotein E-deficient mice with advanced atherosclerosis Pathology International 2000 50 12 929 936 (Pubitemid 32128468)
20. Lerman A., Webster M. W. I., Chesebro J. H., Edwards W. D., Wei C. M., Fuster V., Burnett J. C., Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs Circulation 1993 88 6 2923 2928 (Pubitemid 23360220)
21. Babaei S., Picard P., Ravandi A., Monge J. C., Lee T. C., Cernacek P., Stewart D. J., Blockade of endothelin receptors markedly reduces atherosclerosis in LDL receptor deficient mice: role of endothelin in macrophage foam cell formation Cardiovascular Research 2000 48 1 158 167
22. Barton M., Haudenschild C. C., D'Uscio L. V., Shaw S., Mnter K., Lscher T. F., Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice Proceedings of the National Academy of Sciences of the United States of America 1998 95 24 14367 14372
23. Fukuda G., Khan Z. A., Barbin Y. P., Farhangkhoee H., Tilton R. G., Chakrabarti S., Endothelin-mediated remodeling in aortas of diabetic rats Diabetes/Metabolism Research and Reviews 2005 21 4 367 375 (Pubitemid 40945959)
24. Matsumura Y., Kuro T., Kobayashi Y., Konishi F., Takaoka M., Wessale J. L., Opgenorth T. J., Gariepy C. E., Yanagisawa M., Exaggerated vascular and renal pathology in endothelin-B receptor-deficient rats with deoxycorticosterone acetate-salt hypertension Circulation 2000 102 22 2765 2773
25. Murakoshi N., Miyauchi T., Kakinuma Y., Ohuchi T., Goto K., Yanagisawa M., Yamaguchi I., Vascular endothelin-B receptor system in vivo plays a favorable inhibitory role in vascular remodeling after injury revealed by endothelin-B receptor-knockout mice Circulation 2002 106 15 1991 1998 (Pubitemid 35176307)
26. Kirkby N. S., Duthie K. M., Miller E., Non-endothelial cell endothelin-B receptors limit neointima formation following vascular injury Cardiovascular Research 2012 95 1 19 28
27. Nishida M., Eshiro K., Okada Y., Takaoka M., Matsumura Y., Roles of endothelin ETA and ETB receptors in the pathogenesis of monocrotaline-induced pulmonary hypertension Journal of Cardiovascular Pharmacology 2004 44 2 187 191 (Pubitemid 38982161)
28. Nishida M., Okada Y., Akiyoshi K., Eshiro K., Takaoka M., Gariepy C. E., Yanagisawa M., Matsumura Y., Role of endothelin ETB receptor in the pathogenesis of monocrotaline-induced pulmonary hypertension in rats European Journal of Pharmacology 2004 496 1-3 159 165 (Pubitemid 39024328)
29. Sachidanandam K., Portik-Dobos V., Harris A. K., Hutchinson J. R., Muller E., Johnson M. H., Ergul A., Evidence for vasculoprotective effects of ETB receptors in resistance artery remodeling in diabetes Diabetes 2007 56 11 2753 2758 (Pubitemid 350044918)
30. Sachidanandam K., Portik-Dobos V., Kelly-Cobbs A. I., Ergul A., Dual endothelin receptor antagonism prevents remodeling of resistance arteries in diabetes Canadian Journal of Physiology and Pharmacology 2010 88 6 616 621
31. Bush T. L., Barrett-Connor E., Noncontraceptive estrogen use and cardiovascular disease Epidemiologic Reviews 1985 7 80 104 (Pubitemid 15236002)
32. Godsland I. F., Wynn V., Crook D., Miller N. E., Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions American Heart Journal 1987 114 6 1467 1503 (Pubitemid 18009506)
33. Farhat M. Y., Lavigne M. C., Ramwell P. W., The vascular protective effects of estrogen The FASEB Journal 1996 10 5 615 624 (Pubitemid 26141172)
34. Mendelsohn M. E., Karas R. H., The protective effects of estrogen on the cardiovascular system The New England Journal of Medicine 1999 340 23 1801 1811 (Pubitemid 29266405)
35. Stampfer M. J., Colditz G. A., Willett W. C., Manson J. A. E., Rosner B., Speizer F. E., Hennekens C. H., Postmenopausal estrogen therapy and cardiovascular diseaseten-year follow-up from the Nurses' Health study The New England Journal of Medicine 1991 325 11 756 762
36. Florian M., Freiman A., Magder S., Treatment with 17- -estradiol reduces superoxide production in aorta of ovariectomized rats Steroids 2004 69 13-14 779 787 (Pubitemid 39593390)
37. Miller A. P., Chen Y. F., Xing D., Feng W., Oparil S., Hormone replacement therapy and inflammation: interactions in cardiovascular disease Hypertension 2003 42 4 657 663 (Pubitemid 37237305)
38. Tolbert T., Thompson J. A., Bouchard P., Oparil S., Estrogen-induced vasoprotection is independent of inducible nitric oxide synthase expression: evidence from the mouse carotid artery ligation model Circulation 2001 104 22 2740 2745 (Pubitemid 33108144)
39. Tostes R. C., Fortes Z. B., Callera G. E., Montezano A. C., Touyz R. M., Webb R. C., Carvalho M. H. C., Endothelin, sex and hypertension Clinical Science 2008 114 1-2 85 97
40. Kawanishi H., Hasegawa Y., Nakano D., Ohkita M., Takaoka M., Ohno Y., Matsumura Y., Involvement of the endothelin ETB receptor in gender differences in deoxycorticosterone acetate-salt-induced hypertension Clinical and Experimental Pharmacology and Physiology 2007 34 4 280 285
41. Best P. J. M., Berger P. B., Miller V. M., Lerman A., The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women Annals of Internal Medicine 1998 128 4 285 288 (Pubitemid 28090759)
42. Maeda S., Tanabe T., Miyauchi T., Otsuki T., Sugawara J., Iemitsu M., Kuno S., Ajisaka R., Yamaguchi I., Matsuda M., Aerobic exercise training reduces plasma endothelin-1 concentration in older women Journal of Applied Physiology 2003 95 1 336 341 (Pubitemid 36753818)
43. Miyauchi T., Yanagisawa M., Iida K., Ajisaka R., Suzuki N., Fujino M., Goto K., Masaki T., Sugishita Y., Age- and sex-related variation of plasma endothelin-1 concentration in normal and hypertensive subjects American Heart Journal 1992 123 4, part 1 1092 1093
44. Polderman K. H., Stehouwer C. D., Van Kamp G. J., Dekker G. A., Verheugt F. W., Gooren L. J., Influence of sex hormones on plasma endothelin levels Annals of Internal Medicine 1993 118 6 429 432 (Pubitemid 23081052)
45. Lekontseva O., Chakrabarti S., Davidge S. T., Endothelin in the female vasculature: a role in aging? American Journal of Physiology 2010 298 3 R509 R516
46. Ergul A., Shoemaker K., Puett D., Tackett R. L., Gender differences in the expression of endothelin receptors in human saphenous veins in vitro Journal of Pharmacology and Experimental Therapeutics 1998 285 2 511 517 (Pubitemid 28237426)
47. David F. L., Carvalho M. H., Cobra A. L., Nigro D., Fortes Z. B., Rebouas N. A., Tostes R. C., Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats Hypertension 2001 38 3, part 2 692 696
48. David F. L., Montezano A. C., Rebouas N. A., Nigro D., Fortes Z. B., Carvalho M. H. C., Tostes R. C. A., Gender differences in vascular expression of endothelin and ETA/ETB receptors, but not in calcium handling mechanisms, in deoxycorticosterone acetate-salt hypertension Brazilian Journal of Medical and Biological Research 2002 35 9 1061 1068 (Pubitemid 35476804)
49. Pedersen S. H., Nielsen L. B., Mortensen A., Nilas L., Ottesen B., Progestins oppose the effects of estradiol on the endothelin-1 receptor type B in coronary arteries from ovariectomized hyperlipidemic rabbits Menopause 2008 15 3 503 510 (Pubitemid 351656756)
50. Chen S. J., Li H., Durand J., Oparil S., Chen Y. F., Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery Circulation 1996 93 3 577 584 (Pubitemid 26043619)
51. Grady D., Rubin S. M., Petitti D. B., Fox C. S., Black D., Ettinger B., Ernster V. L., Cummings S. R., Hormone therapy to prevent disease and prolong life in postmenopausal women Annals of Internal Medicine 1992 117 12 1016 1037
52. Walsh B. W., Schiff I., Rosner B., Greenberg L., Ravnikar V., Sacks F. M., Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins The New England Journal of Medicine 1991 325 17 1196 1204
53. Hulley S., Grady D., Bush T., Furberg C., Herrington D., Riggs B., Vittinghoff E., Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women The Journal of the American Medical Association 1998 280 7 605 613 (Pubitemid 28502636)
54. Rossouw J. E., Anderson G. L., Prentice R. L., Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial The Journal of the American Medical Association 2002 288 3 321 333 (Pubitemid 34761611)